Acid suppression increases rates of Barrett's esophagus and esophageal injury in the presence of duodenal reflux

Surgery

Volumn 151, Issue 3, 2012, Pages 382-390

  Nasr, Ayman O ^a   Dillon, Mary F ^a   Conlon, Susie ^a   Downey, Paul ^a   Chen, Gang ^b   Ireland, Adrian ^b   Leen, Eamon ^a   Bouchier Hayes, David ^b   Walsh, Thomas N ^a  

^a Royal College of Surgeons in Ireland   (Ireland)

^b BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; OMEPRAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BARRETT ESOPHAGUS; CONTROLLED STUDY; DISEASE SEVERITY; DUODENOGASTRIC REFLUX; DUODENOSTOMY; EDEMA; ESOPHAGUS INJURY; GASTRECTOMY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTACIDS; BARRETT ESOPHAGUS; DISEASE MODELS, ANIMAL; DUODENOGASTRIC REFLUX; DUODENOSTOMY; ESOPHAGOSTOMY; ESOPHAGUS; GASTRECTOMY; GASTRIC ACID; KI-67 ANTIGEN; MALE; METAPLASIA; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTON PUMP INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84857053733     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2011.08.021     Document Type: Article

References (51)

1. W.J. Blot, S.S. Devesa, and R.W. Kneller Rising incidence of adenocarcinoma of the esophagus and gastric cardia JAMA 265 1991 1287 1289
2. S.S. Devesa, W.J. Blot, and J.F. Fraumeni Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States Cancer 83 1998 2049 2053 (Pubitemid 28525384)
3. L.M. Brown, S.S. Devesa, and W.H. Chow Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age Natl Cancer Inst 100 2008 1184 1187
4. F.T. Peters, S. Ganesh, and E.J. Kuipers Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study Gut 1999 45489 45494
5. E.M. Faybush, and R.E. Sampliner Randomized trials in the treatment of Barrett's esophagus Dis Esophagus 18 2005 291 297 (Pubitemid 43904773)
6. P. Parrilla, L.F. Martínez de Haro, and A. Ortiz Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus Ann Surg 237 2003 291 298 (Pubitemid 38176442)
7. J.R. Rees, P. Lao-Sirieix, and A. Wong Treatment for Barrett's oesophagus Cochrane Database Syst Rev 1 2010 CD004060
8. M.F. Dixon, P.M. Neville, and N.P. Mapstone Bile reflux gastritis and Barrett's oesophagus: further evidence of a role for duodenogastro-oesphageal reflux? Gut 49 2001 359 363 (Pubitemid 32802570)
9. M. Fein, J. Maroske, and K.H. Fuchs Importance of duodenogastric reflux in gastro-oesophageal reflux disease Br J Surg 93 2006 1475 1482 (Pubitemid 44893648)
10. G.H. Koek, D. Sifrim, and T. Lerut Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus Gut 57 2008 1056 1064
11. M.T. Caldwell, P. Lawlor, and P.J. Byrne Ambulatory oesophageal bile reflux monitoring in Barrett's oesophagus Br J Surg 82 1995 657 660
12. H.J. Stein, W.K. Kauer, and H. Feussner Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and Nissen fundoplication J Gastrointest Surg 2 1998 333 341
13. R.E. Marshall, A. Anggiansah, and W.J. Owen Bile in the oesophagus: clinical relevance and ambulatory detection Br J Surg 84 1997 21 28 (Pubitemid 27033094)
14. D. Nehra, P. Howell, and C.P. Williams Toxic bile acids in gastro-oesphageal reflux disease: influence of gastric acidity Gut 44 1999 598 602 (Pubitemid 29195903)
15. W.K. Kauer, J.H. Peters, and T.R. DeMeester Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized Ann Surg 222 1995 525 531
16. G. Champion, J.E. Richter, and M.F. Vaezi Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus Gastroenterology 107 1994 747 754 (Pubitemid 24265522)
17. M.F. Vaezi, S. Singh, and J.E. Richter Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies Gastroenterology 108 1995 1897 1907
18. A.P. Ireland, J.H. Peters, and T.C. Smyrk Gastric juice protects against the development of esophageal adenocarcinoma in the rat Ann Surg 224 1996 358 370
19. R. Fossmark, G. Qvigstad, and H.L. Waldum Gastric cancer: animal studies on the risk of hypoacidity and hypergastrinemia World J Gastroenterol 14 2008 1646 1651 (Pubitemid 351493369)
20. K.E. McColl, E. el-Omar, and D. Gillen Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy Br Med Bull 54 1998 121 138 (Pubitemid 28105321)
21. P. Netzer, A. Gut, and R. Brundler Influence if pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesphagitis Aliment Pharmacol 15 2001 1375 1384 (Pubitemid 32835544)
22. R.E. Marshall, A. Anggiansah, and D.K. Manifold Effect of omeprazole 20mg twice daily on duodenogastric and gastro-oesophageal bile reflux in Barrett's oesophagus Gut 43 1998 603 606 (Pubitemid 28520091)
23. M. Fein, J.H. Peters, P. Chandrasoma, A.P. Ireland, S. Oberg, and M.P. Ritter Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen J Gastrointest Surg 2 1998 260 268 (Pubitemid 128409612)
24. D. Atkins, K.-A. Reiffen, C.L. Tegtmeier, H. Winther, M.S. Bonato, and S. Storkel Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: variation in staining intensity due to choice of fixative and storage time of tissue sections J Histochem Cytochem 52 2004 893 901 (Pubitemid 38857154)
25. C.J. Peters, and R.C. Fitzgerald Systematic review: the application of molecular pathogenesis to prevention and treatment of oesophageal adenocarcinoma Aliment Pharmacol Ther 25 2007 1253 1269 (Pubitemid 46763460)
26. H. Ohshima, H. Tazawa, and B.S. Sylla Prevention of human cancer by modulation of chronic inflammatory processes Mutat Res 591 2005 110 122 (Pubitemid 41654843)
27. T.A. Gonda, S. Tu, and T.C. Wang Chronic inflammation, the tumor microenvironment and carcinogenesis Cell Cycle 8 2009 2005 2013
28. H.Y. Zhang, S.J. Spechler, and R.F. Souza Esophageal adenocarcinoma arising in Barrett esophagus Cancer Lett 275 2009 170 177
29. S.M. Lagarde, F.J. ten Kate, and D.J. Richel Molecular prognostic factors in adenocarcinoma of the esophagus and gastroesophageal junction Ann Surg Oncol 14 2007 977 991 (Pubitemid 46175350)
30. A. Kyrgidis, J. Kountouras, and C. Zavos New molecular concepts of Barrett's esophagus: clinical implications and biomarkers J Surg Res 125 2005 189 212 (Pubitemid 40602392)
31. W. Polkowski, J.J. van Lanschot, and F.J. Ten Kate The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequence Surg Oncol 4 1995 163 171
32. M.K. Hong, W.B. Laskin, and B.E. Herman Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus Cancer 75 1995 423 429
33. M. Binato, R.R. Gurski, and R.B. Fagundes P53 and Ki-67 overexpression in gastroesophageal reflux disease - Barrett's esophagus and adenocarcinoma sequence Dis Esophagus 22 2009 588 595
34. M. Feith, H.J. Stein, and J. Mueller Malignant degeneration of Barrett's esophagus: the role of the Ki-67 proliferation fraction, expression of E-cadherin and p53 Dis Esophagus 17 2004 322 327 (Pubitemid 40123809)
35. T. Fujii, S. Nakagawa, and M. Hanzawa Immunohistological study of cell cycle-related factors, oncogene expression, and cell proliferation in adenocarcinoma developed in Barrett's esophagus Oncol Rep 10 2003 427 431
36. B.S. Kaur, N. Khamnehei, and M. Iravani Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett's esophagus Gastroenterology 123 2002 60 67 (Pubitemid 34747526)
37. P. Gillen, M. McDermott, and D. Grehan Proliferating cell nuclear antigen in the assessment of Barrett's mucosa Br J Surg 81 1994 1766 1768 (Pubitemid 24372365)
38. D. Arnold, S. Peinert, and W. Voigt Epidermal growth factor receptor tyrosine kinase inhibitors: present and future role in gastrointestinal cancer treatment: a review Oncologist 11 2006 602 611 (Pubitemid 43967615)
39. W.W. Ma, and M. Hidalgo Exploiting novel molecular targets in gastrointestinal cancers World J Gastroenterol 13 2007 5845 5856 (Pubitemid 350148501)
40. W.P. Tew, D.P. Kelsen, and D.H. Ilson Targeted therapies for esophageal cancer Oncologist 10 2005 590 601 (Pubitemid 41429122)
41. N.E. Avissar, L. Toia, and Y. Hu Bile acid alone, or in combination with acid, induces CDX2 expression through activation of the epidermal growth factor receptor (EGFR) J Gastrointest Surg 13 2009 212 222
42. K.H. Moore, P. Barry, and J. Burn Adenocarcinoma of the rat esophagus in the presence of a proton pump inhibitor: a pilot study Dis Esophagus 14 2001 17 22 (Pubitemid 32700505)
43. T. Miyashita, F.A. Shah, and G.P. Marti Rabeprazole impedes the development of reflux-induced esophageal cancer in a surgical rat model Dig Dis Sci 56 2011 1309 1314
44. A. Csendes, A.M. Burgos, and G. Smok Latest results (12-21 years) of a prospective randomized study comparing Billroth II and Roux-en-Y anastomosis after a partial gastrectomy plus vagotomy in patients with duodenal ulcers Ann Surg 249 2009 189 194
45. A. Csendes, and I. Braghetto Development of de-novo Barrett's esophagus after esophagogastric surgery in human subjects Eur Surg 41/3 2009 120 125
46. L. Duan, A.H. Wu, and J. Sullivan-Halley Antacid drug use and risk of esophageal and gastric adenocarcinomas in Los Angeles County Cancer Epidemiol Biomarkers Prev 18 2009 526 533
47. D.C. Farrow, T.L. Vaughan, and C. Sweeney Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer Cancer Causes Control 11 2000 231 238 (Pubitemid 30182140)
48. J. Lagergren, R. Bergström, and A. Lindgren Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma N Engl J Med 340 1999 825 831 (Pubitemid 29142625)
49. L.A. García Rodríguez, J. Lagergren, and M. Lindblad Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK Gut 55 2006 1538 1544 (Pubitemid 44629198)
50. G.H. Koek, D. Sifrim, and T. Lerut Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus Gut 57 2008 1056 1064
51. N.J. Talley, and S. Abeygunasekera Bile reflux and Barrett's oesophagus: innocent bystander or sinister companion? Dig Liver Dis 34 2002 246 248 (Pubitemid 34461055)